Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach cramping on Wegovy is common, particularly in the first few weeks of treatment or after a dose increase — and most people find it settles on its own as the body adjusts. Semaglutide slows the speed at which food leaves your stomach, and that change in gut rhythm is usually what lies behind the cramping. It is a prescription-only medicine, and a prescriber reviews your suitability before any treatment begins. If your cramping is severe, persistent, or radiates to your back, those are signs to seek medical advice promptly — this page explains exactly what to watch for and why.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people who experience stomach cramps on Wegovy conclude, fairly quickly, that their body is rejecting the medicine. It feels logical. But this is almost always the wrong reading of what's happening. Cramping in the early weeks is a physiological response to a meaningful change in how your gut works, not a sign that treatment needs to stop.
Semaglutide activates GLP-1 receptors throughout the gut, slowing the rate at which your stomach empties and changing the pace at which food moves along the intestine. That altered rhythm produces a range of gastrointestinal sensations, of which cramping is one. The NHS medicines information for semaglutide lists stomach pain and cramps among the common side effects, alongside nausea, bloating, diarrhoea and constipation.
The timing matters too. Cramping tends to be most noticeable in the first week or two at any given dose, then gradually quietens. The dose-escalation schedule (stepping up every four weeks or so, under your prescriber's guidance) exists partly to give your gut that adjustment window. For most people, the pattern is: new dose, a few uncomfortable days, then a period of relative calm. That said, everyone's gut is different, and some people experience very little disruption at all. If you are finding cramps hard to manage, it is worth discussing timing, meal size and composition with your prescriber before considering whether treatment is right for you.
You can read more about how the medicine works and what the broader side-effect picture looks like on our Wegovy overview page.
If your cramping seemed to improve and then came back, a recent dose increase is almost certainly why. Each step on the semaglutide escalation ladder represents a stronger signal to your gut's receptors, and the pattern of discomfort that appeared when you started can revisit briefly at each new level.
This is not cause for alarm, but it is useful to know in advance. People who are forewarned tend to ride out the few uncomfortable days without assuming something has gone wrong. Those who aren't can find themselves anxious, cutting meals unnecessarily short, or stopping treatment prematurely, and losing the clinical benefit that was building.
Practical adjustments that our prescribers often discuss with patients: eating smaller portions spread across the day rather than two or three larger meals; chewing slowly and stopping before you feel full; pulling back on fried or very fatty foods during the adjustment window, since high-fat meals travel through a slowed stomach particularly sluggishly. Staying well hydrated also helps, especially if cramping is accompanied by loose stools.
Some people find that cramping arrives more intensely overnight, when they are lying down and digestion slows further. If that is your experience, our page on Wegovy stomach cramps at night looks at that pattern specifically.
One detail worth building into your routine: if your pen lives in the fridge door, keeping it there consistently matters, check the Patient Information Leaflet for the exact window during which a pen removed from the fridge remains usable, since storage affects medicine quality and that in turn can affect tolerability.
The reassurance above has a firm boundary. There is a version of stomach pain on GLP-1 medicines that should not be managed at home by adjusting your diet and waiting. In January 2026, the MHRA published a Drug Safety Update on GLP-1 receptor agonists that specifically highlighted acute pancreatitis: severe stomach pain that comes on strongly and may radiate through to the back, often accompanied by vomiting, is a symptom that requires same-day medical attention.
Pancreatitis is infrequent, but it can be serious. The key features that distinguish it from ordinary adjustment cramping are the intensity, the persistence (it does not come and go with meals in the usual way) and that radiating quality towards the back. Ordinary Wegovy cramps tend to track food: they arrive after eating, particularly after something rich or large, and ease with time. Pancreatitis pain does not follow that pattern.
Gallbladder problems are a separate but related concern on GLP-1 medicines. Pain in the upper right abdomen, especially after eating fatty food, can indicate gallstones, which occur at a higher rate during significant weight loss of any kind. Again, this is distinct in character from the general cramping most people experience.
If you are uncertain which kind of pain you are dealing with, do not sit with that uncertainty. Contact your prescriber, call 111, or go to A&E if the pain is severe. You can also report any suspected side effects directly through the MHRA's Yellow Card scheme, which helps regulators track patterns across the whole population on treatment.
Our dedicated page on stomach cramps after a Wegovy injection covers the injection-day timing question in more detail if that pattern is what you are noticing.
Most adjustment cramping does not need medical intervention. Small, practical changes to how and what you eat tend to be the most effective lever. Beyond the dietary adjustments mentioned above: some people find that taking their injection on a day when they have a quieter schedule the day after makes the adjustment window easier to manage, there is no clinical reason one day is better than another, but rest genuinely helps some people.
If cramping has persisted beyond two to three weeks at a stable dose, or if it is significantly affecting your daily life, that is the right moment to contact your prescriber rather than managing alone. The medicine's dose escalation schedule can sometimes be slowed, which is a legitimate clinical option. What matters is that the decision is made with someone who knows your health picture, not by stopping abruptly without guidance.
There is also the straightforward question of whether Wegovy is the right choice for you specifically, a question that cuts across how well the medicine works and your individual tolerance. That is exactly the kind of conversation a prescriber is there for. If you have not yet started treatment and are weighing your options, our free consultation connects you with a GPhC-registered Independent Prescriber who can assess your suitability the same day you apply. The cost of treatment and what that includes is set out on our Wegovy pricing page if that is useful context.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.